{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T18:36:23Z","timestamp":1766428583574,"version":"3.40.5"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatol Commun"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Splanchnic vasodilatation contributes to the development and aggravation of portal hypertension (PHT). We previously demonstrated that in cirrhosis, angiotensin\u2010 mediates splanchnic vasodilatation through the Mas receptor (MasR). In this study, we investigated whether the recently characterized second receptor for angiotensin\u2010(1\u20137), Mas\u2010related G protein\u2010coupled receptor type D (MrgD), contributes to splanchnic vasodilatation in cirrhotic and noncirrhotic PHT. Splanchnic vascular hemodynamic and portal pressure were determined in two rat models of cirrhotic PHT and a rat model with noncirrhotic PHT, treated with either MrgD blocker D\u2010Pro<jats:sup>7<\/jats:sup>\u2010Ang\u2010(1\u20107) (D\u2010Pro) or MasR blocker A779. Gene and protein expression of MrgD and MasR were measured in splanchnic vessels and livers of cirrhotic and healthy rats and in patients with cirrhosis and healthy subjects. Mesenteric resistance vessels isolated from cirrhotic rats were used in myographs to study their vasodilatory properties. MrgD was up\u2010regulated in cirrhotic splanchnic vessels but not in the liver. In cirrhotic rats, treatment with D\u2010Pro but not A779 completely restored splanchnic vascular resistance to a healthy level, resulting in a 33% reduction in portal pressure. Mesenteric vessels pretreated with D\u2010Pro but not with A779 failed to relax in response to acetylcholine. There was no splanchnic vascular MrgD or MasR up\u2010regulation in noncirrhotic PHT; thus, receptor blockers had no effect on splanchnic hemodynamics. <jats:italic toggle=\"yes\">Conclusion<\/jats:italic>: MrgD plays a major role in the development of cirrhotic PHT and is a promising target for the development of novel therapies to treat PHT in cirrhosis. Moreover, neither MrgD nor MasR contributes to noncirrhotic PHT.<\/jats:p>","DOI":"10.1002\/hep4.1987","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T09:23:49Z","timestamp":1653038629000},"page":"2523-2537","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Mas\u2010related G protein\u2010coupled receptor type D antagonism improves portal hypertension in cirrhotic rats"],"prefix":"10.1097","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5841-057X","authenticated-orcid":false,"given":"Lakmie S.","family":"Gunarathne","sequence":"first","affiliation":[{"name":"Department of Medicine,University of Melbourne,Austin Health,Heidelberg,Victoria,Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3326-3654","authenticated-orcid":false,"given":"Indu G.","family":"Rajapaksha","sequence":"additional","affiliation":[{"name":"Department of Medicine,University of Melbourne,Austin Health,Heidelberg,Victoria,Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Casey","sequence":"additional","affiliation":[{"name":"Liver Unit,Austin Health,Heidelberg,Victoria,Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tawar","family":"Qaradakhi","sequence":"additional","affiliation":[{"name":"College of Health and Biomedicine,Victoria University,Werribee,Victoria,Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Zulli","sequence":"additional","affiliation":[{"name":"College of Health and Biomedicine,Victoria University,Werribee,Victoria,Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harinda","family":"Rajapaksha","sequence":"additional","affiliation":[{"name":"Oracle Australia,Melbourne,Victoria,Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonel","family":"Trebicka","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine,University Clinic Frankfurt,Frankfurt,Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter W.","family":"Angus","sequence":"additional","affiliation":[{"name":"Department of Medicine,University of Melbourne,Austin Health,Heidelberg,Victoria,Australia"},{"name":"Department of Gastroenterology,Austin Health,Heidelberg,Victoria,Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandana B.","family":"Herath","sequence":"additional","affiliation":[{"name":"Department of Medicine,University of Melbourne,Austin Health,Heidelberg,Victoria,Australia"},{"name":"South Western Sydney Clinical School,Faculty of Medicine,University of New South Wales,Sydney,Victoria,Australia"},{"name":"Ingham Institute for Applied Medical Research,Liverpool,New South Wales,Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"key":"hep41987-bib-0001-20241118","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.3748\/wjg.v26.i40.6111","article-title":"Cirrhotic portal hypertension: from pathophysiology to novel therapeutics","volume":"26","year":"2020","journal-title":"World J Gastroenterol"},{"key":"hep41987-bib-0002-20241118","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jhep.2010.03.013","article-title":"Renin\u2010angiotensin\u2010aldosterone inhibitors in the reduction of portal pressure: a systematic review and meta\u2010analysis","volume":"53","year":"2010","journal-title":"J Hepatol"},{"key":"hep41987-bib-0003-20241118","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0016-5085(00)70368-4","article-title":"Angiotensin II induces contraction and proliferation of human hepatic stellate cells","volume":"118","year":"2000","journal-title":"Gastroenterology"},{"key":"hep41987-bib-0004-20241118","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1172\/JCI18212","article-title":"NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis","volume":"112","year":"2003","journal-title":"J Clin Invest"},{"key":"hep41987-bib-0005-20241118","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1053\/j.gastro.2013.06.036","article-title":"Activation of the MAS receptor by angiotensin\u2010(1\u20107) in the renin\u2010angiotensin system mediates mesenteric vasodilatation in cirrhosis","volume":"145","year":"2013","journal-title":"Gastroenterology"},{"key":"hep41987-bib-0006-20241118","article-title":"Blockade of Mas receptor or Mas\u2010related G\u2010protein coupled receptor type D reduces portal pressure in cirrhotic but not in non\u2010cirrhotic portal hypertensive rats","volume":"10","year":"2019","journal-title":"Front Physiol"},{"key":"hep41987-bib-0007-20241118","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.3748\/wjg.15.2512","article-title":"Relationship between angiotensin\u2010(1\u20107) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis","volume":"15","year":"2009","journal-title":"World J Gastroenterol"},{"key":"hep41987-bib-0008-20241118","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.peptides.2018.08.008","article-title":"Effects of angiotensin\u2010(1\u20107) and angiotensin II on vascular tone in human cirrhotic splanchnic vessels","volume":"108","year":"2018","journal-title":"Peptides"},{"key":"hep41987-bib-0009-20241118","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/HYPERTENSIONAHA.116.07572","article-title":"G\u2010protein\u2010coupled receptor MrgD is a receptor for angiotensin\u2010(1\u20107) involving adenylyl cyclase, cAMP, and phosphokinase A","volume":"68","year":"2016","journal-title":"Hypertension"},{"key":"hep41987-bib-0010-20241118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4291\/wjgp.v4.i1.1","article-title":"Therapeutic potential of targeting the renin angiotensin system in portal hypertension","volume":"4","year":"2013","journal-title":"World J Gastrointest Pathophysiol"},{"key":"hep41987-bib-0011-20241118","doi-asserted-by":"crossref","first-page":"G98","DOI":"10.1152\/ajpgi.00045.2009","article-title":"Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2","volume":"297","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"hep41987-bib-0012-20241118","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/CS20080647","article-title":"Angiotensin\u2010(1\u20107), an alternative metabolite of the renin\u2010angiotensin system, is up\u2010regulated in human liver disease and has antifibrotic activity in the bile\u2010duct\u2010ligated rat","volume":"117","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"hep41987-bib-0013-20241118","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/hep4.1434","article-title":"Liver\u2010targeted angiotensin converting enzyme 2 therapy inhibits chronic biliary fibrosis in multiple drug\u2010resistant gene 2\u2010knockout mice","volume":"3","year":"2019","journal-title":"Hepatol Commun"},{"key":"hep41987-bib-0014-20241118","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jhep.2007.03.008","article-title":"Upregulation of hepatic angiotensin\u2010converting enzyme 2 (ACE2) and angiotensin\u2010(1\u20107) levels in experimental biliary fibrosis","volume":"47","year":"2007","journal-title":"J Hepatol"},{"key":"hep41987-bib-0015-20241118","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1136\/gut.2004.062398","article-title":"Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2","volume":"54","year":"2005","journal-title":"Gut"},{"key":"hep41987-bib-0016-20241118","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin\u2010(1\u20107) is an endogenous ligand for the G protein\u2010coupled receptor Mas","volume":"100","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"hep41987-bib-0017-20241118","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.peptides.2006.10.007","article-title":"Evidence for a new angiotensin\u2010(1\u20107) receptor subtype in the aorta of Sprague\u2010Dawley rats","volume":"28","year":"2007","journal-title":"Peptides"},{"key":"hep41987-bib-0018-20241118","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCRESAHA.113.301077","article-title":"Discovery and characterization of alamandine: a novel component of the renin\u2010angiotensin system","volume":"112","year":"2013","journal-title":"Circ Res"},{"key":"hep41987-bib-0019-20241118","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11010-008-9884-4","article-title":"Angiotensin metabolites can stimulate receptors of the Mas\u2010related genes family","volume":"319","year":"2008","journal-title":"Mol Cell Biochem"},{"key":"hep41987-bib-0020-20241118","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/hep.28686","article-title":"Inhibition of epoxyeicosatrienoic acid production in rats with cirrhosis has beneficial effects on portal hypertension by reducing splanchnic vasodilation","volume":"64","year":"2016","journal-title":"Hepatology"},{"key":"hep41987-bib-0021-20241118","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.abb.2010.02.005","article-title":"PKA\u2010mediated effect of MAS receptor in counteracting angiotensin II\u2010stimulated renal Na+\u2010ATPase","volume":"496","year":"2010","journal-title":"Arch Biochem Biophys"},{"key":"hep41987-bib-0022-20241118","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/01.HYP.0000251865.35728.2f","article-title":"Angiotensin\u2010(1\u20107) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt\u2010dependent pathways","volume":"49","year":"2007","journal-title":"Hypertension"},{"key":"hep41987-bib-0023-20241118","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00005344-199611000-00014","article-title":"The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium\u2010dependent relaxations in rat mesenteric circulation","volume":"28","year":"1996","journal-title":"J Cardiovasc Pharmacol"},{"key":"hep41987-bib-0024-20241118","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0006-2952(97)00039-7","article-title":"Hyperpolarizing factors","volume":"54","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"hep41987-bib-0025-20241118","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1098-8823(03)00077-7","article-title":"Role of cytochrome P450\u2010dependent arachidonic acid metabolites in liver physiology and pathophysiology","volume":"72","year":"2003","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"hep41987-bib-0026-20241118","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.lfs.2006.09.007","article-title":"Effects of genetic deletion of angiotensin\u2010(1\u20107) receptor Mas on cardiac function during ischemia\/reperfusion in the isolated perfused mouse heart","volume":"80","year":"2006","journal-title":"Life Sci"},{"key":"hep41987-bib-0027-20241118","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/01.HYP.0000215289.51180.5c","article-title":"Impairment of in vitro and in vivo heart function in angiotensin\u2010(1\u20107) receptor MAS knockout mice","volume":"47","year":"2006","journal-title":"Hypertension"},{"key":"hep41987-bib-0028-20241118","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ki.2009.61","article-title":"Genetic deletion of the angiotensin\u2010(1\u20107) receptor Mas leads to glomerular hyperfiltration and microalbuminuria","volume":"75","year":"2009","journal-title":"Kidney Int"},{"key":"hep41987-bib-0029-20241118","article-title":"Hemodynamic effects of the non\u2010peptidic angiotensin\u2010(1\u20107) agonist AVE0991 in liver cirrhosis","volume":"10","year":"2015","journal-title":"PLoS One"},{"key":"hep41987-bib-0030-20241118","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2006.10.018","article-title":"The renin\u2010angiotensin system in a rat model of hepatic fibrosis: evidence for a protective role of angiotensin\u2010(1\u20107)","volume":"46","year":"2007","journal-title":"J Hepatol"},{"key":"hep41987-bib-0031-20241118","first-page":"G371","article-title":"Measurement of portal\u2010systemic shunting in the rat by using gamma\u2010labeled microspheres","volume":"240","year":"1981","journal-title":"Am J Physiol"},{"key":"hep41987-bib-0032-20241118","first-page":"G52","article-title":"Hyperdynamic circulation in portal\u2010hypertensive rat model: a primary factor for maintenance of chronic portal hypertension","volume":"244","year":"1983","journal-title":"Am J Physiol"},{"key":"hep41987-bib-0033-20241118","first-page":"G618","article-title":"Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model","volume":"248","year":"1985","journal-title":"Am J Physiol"},{"key":"hep41987-bib-0034-20241118","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.3748\/wjg.v12.i41.6577","article-title":"Animal models of portal hypertension","volume":"12","year":"2006","journal-title":"World J Gastroenterol"}],"container-title":["Hepatology Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep4.1987","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep4.1987","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1002\/hep4.1987","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T12:00:51Z","timestamp":1731931251000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1002\/hep4.1987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1002\/hep4.1987","relation":{},"ISSN":["2471-254X","2471-254X"],"issn-type":[{"type":"print","value":"2471-254X"},{"type":"electronic","value":"2471-254X"}],"subject":[],"published":{"date-parts":[[2022,5,20]]},"assertion":[{"value":"2021-10-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}